Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria M Pratt

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2020
Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE NetworkKenneth D Levy, Kathryn Blake, Colette Fletcher-Hoppe, et al.
The Journal of Molecular Diagnostics : JMD|July 20, 2024
DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation ConsortiumVictoria M Pratt, Larisa H Cavallari, Makenzie L Fulmer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 17, 2004
Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panelMichael S Watson, Garry R Cutting, Robert J Desnick, et al.
Clinical Pharmacology and Therapeutics|August 22, 2024
Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons LearnedTyler Shugg, Emma M Tillman, Amy M Breman, et al.
Life (Basel, Switzerland)|April 1, 2020
Implementation of a Renal Precision Medicine Program: Clinician Attitudes and AcceptanceKatherine M Spiech, Purnima R Tripathy, Alex M Woodcock, et al.
Clinical Pharmacology and Therapeutics|June 10, 2021
PharmVar GeneFocus: CYP2C9Katrin Sangkuhl, Karla Claudio-Campos, Larisa H Cavallari, et al.
Clinical Pharmacology and Therapeutics|May 12, 2025
Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y<sub>12</sub> Inhibitor PrescribingAshley N Springer, Leah A Alicea, Yemi Gafari, et al.
Clinical Pharmacology and Therapeutics|February 24, 2022
PharmVar GeneFocus: CYP3A5Cristina Rodriguez-Antona, Jessica L Savieo, Volker M Lauschke, et al.
Clinical Pharmacology and Therapeutics|July 1, 2020
PharmVar GeneFocus: CYP2C19Mariana R Botton, Michelle Whirl-Carrillo, Andria L Del Tredici, et al.
Journal of Personalized Medicine|June 2, 2021
Multi-Institutional Implementation of Clinical Decision Support for <i>APOL1, NAT2,</i> and <i>YEATS4</i> Genotyping in Antihypertensive ManagementThomas M Schneider, Michael T Eadon, Rhonda M Cooper-DeHoff, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2020
Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE NetworkKenneth D Levy, Kathryn Blake, Colette Fletcher-Hoppe, et al.
The Journal of Molecular Diagnostics : JMD|July 20, 2024
DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation ConsortiumVictoria M Pratt, Larisa H Cavallari, Makenzie L Fulmer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 17, 2004
Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panelMichael S Watson, Garry R Cutting, Robert J Desnick, et al.
Clinical Pharmacology and Therapeutics|August 22, 2024
Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons LearnedTyler Shugg, Emma M Tillman, Amy M Breman, et al.
Life (Basel, Switzerland)|April 1, 2020
Implementation of a Renal Precision Medicine Program: Clinician Attitudes and AcceptanceKatherine M Spiech, Purnima R Tripathy, Alex M Woodcock, et al.
Clinical Pharmacology and Therapeutics|June 10, 2021
PharmVar GeneFocus: CYP2C9Katrin Sangkuhl, Karla Claudio-Campos, Larisa H Cavallari, et al.
Clinical Pharmacology and Therapeutics|May 12, 2025
Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y<sub>12</sub> Inhibitor PrescribingAshley N Springer, Leah A Alicea, Yemi Gafari, et al.
Clinical Pharmacology and Therapeutics|February 24, 2022
PharmVar GeneFocus: CYP3A5Cristina Rodriguez-Antona, Jessica L Savieo, Volker M Lauschke, et al.
Clinical Pharmacology and Therapeutics|July 1, 2020
PharmVar GeneFocus: CYP2C19Mariana R Botton, Michelle Whirl-Carrillo, Andria L Del Tredici, et al.
Journal of Personalized Medicine|June 2, 2021
Multi-Institutional Implementation of Clinical Decision Support for <i>APOL1, NAT2,</i> and <i>YEATS4</i> Genotyping in Antihypertensive ManagementThomas M Schneider, Michael T Eadon, Rhonda M Cooper-DeHoff, et al.
Pageof 9